retatrutide glp-1 gip glucagon receptor agonist triple Sweet Temptation, bitter Truth: Diabetes in the Research Spotlight Triple GLP-1 / GIP /
Description
The disproportionality signal they identified disappeared only when they removed this subgroup of patients from their analysis
in 12 HFpEF patients who underwent bariatric surgery, an improvement in Minnesota Living With Heart Failure score (p=0.018), a lowering in LV myocardial mass (p=0.001) and a reduction in NYHA functional class of HF were observed at 3 and 6 months after surgery
About 6 to 10 extra cases per 10,000 users over 3 years
It works best when used with lifestyle modifications such as exercise and ha ealthy diet
Furthermore, the odds ratio increases as the cumulative dose increases
[DOI] [PMC free article] [PubMed] [Google Scholar] 241.Maudrie T.L., Colon-Ramos U., Harper K.M., Jock B.W., Gittelsohn J
